Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients (NCT06890078) | Clinical Trial Compass
RecruitingNot Applicable
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
France240 participantsStarted 2025-07-08
Plain-language summary
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* adult patients with suspected pneumocystis
* with an indication for bronchial fibroscopy for BAL or induced sputum
* no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition
Exclusion Criteria:
* Pneumocystis treated for more than 72 hours
* pregnancy/breast-feeding
* adult patients deprived of liberty, protected
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study seems to focus on improving how Pneumocystis is diagnosed in immunocompromised patients — how would participating actually affect my treatment, or would I just be contributing samples or data without changing what care I receive?
2Since this is a diagnostic study and not testing a new drug or treatment, what tests or procedures would I need to undergo that I wouldn't normally have as part of my standard care?
3Given that the trial is measuring how well different diagnostic methods correlate with each other, does that mean there's still uncertainty about the best way to diagnose Pneumocystis, and how does that uncertainty affect my current situation?
4Because I'm immunocompromised, are there any additional risks to me specifically from taking part in this study — for example, from extra blood draws, fluid samples, or more frequent clinic visits?
5Would joining this trial delay or interfere with starting any standard treatment I might need for Pneumocystis or my underlying condition?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.